![Anna Baran-Djokovic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Anna Baran-Djokovic was the founder of Cytovia Therapeutics, Inc., founded in 2018, where the title held was Vice President-Investor Relations from 2018 to 2023.
The current job is Senior Vice President-Investor Relations at Medicus Pharma Ltd. Former jobs include Senior Director-IR & Corporate Affairs at Immune Pharmaceuticals, Inc., and Senior Vice President-Investor Relations at INVO Fertility, Inc. from 2023 to 2025.
Education includes undergraduate studies at Warsaw School of Economics and graduate studies at the University of Warsaw.
Postes actifs de Anna Baran-Djokovic
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Anna Baran-Djokovic
| Sociétés | Poste | Fin |
|---|---|---|
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Fondateur | 01/10/2023 |
| IMMUNE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Formation de Anna Baran-Djokovic
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Warsaw School of Economics
 Warsaw School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warsaw
 University of Warsaw Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
